Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | AMGN | GILD | VRTX | BIIB |
| Company | Blueprint Medicines Corp | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 88.45 | 264.63 | 66.25 | 394.72 | 190.72 |
| High | 89.89 | 269.38 | 66.83 | 396.84 | 194.52 |
| Low | 84.62 | 260.68 | 66.19 | 391.25 | 189.44 |
| Last | 86.85 | 268.93 | 66.78 | 394.28 | 194.38 |
| Change | -2.05 | +6.18 | +0.62 | +0.80 | +3.86 |
| % Change | -2.31% | +2.35% | +0.94% | +0.20% | +2.03% |
| Volume | 799,671 | 3,373,487 | 10,654,855 | 1,302,693 | 1,598,970 |
| 20-Day Average Volume | 588,509 | 2,246,094 | 6,455,813 | 929,855 | 1,140,964 |
| Previous Close | 88.90 | 262.75 | 66.16 | 393.48 | 190.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 90.31 | 272.56 | 69.90 | 405.52 | 205.03 |
| 20-Day Raw Stochastic | 19.89% | 29.59% | 11.04% | 10.74% | 15.51% |
| 20-Day Relative Strength | 47.24% | 43.95% | 31.41% | 37.76% | 32.40% |
| Weighted Alpha | +77.12 | +7.67 | -24.29 | +15.95 | -36.99 |
| Today's Opinion | 56% Buy | 56% Sell | 100% Sell | 8% Buy | 100% Sell |
| Previous Opinion | 72% Buy | 56% Sell | 100% Sell | 8% Buy | 100% Sell |
| Last Month's Opinion | 88% Buy | 8% Sell | 72% Sell | 40% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.46% since 04/12/24 | +0.62% since 04/12/24 | -1.90% since 04/12/24 | -0.57% since 04/12/24 | -1.92% since 04/12/24 |
| Low | 84.33 on 04/15/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 91.76 on 04/18/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 402.49 on 04/15/24 | 199.53 on 04/15/24 |
| 1-Month | |||||
| %Chg | -1.27% since 03/19/24 | -1.03% since 03/19/24 | -9.03% since 03/19/24 | -5.04% since 03/19/24 | -11.09% since 03/19/24 |
| Low | 84.33 on 04/15/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 97.00 on 04/01/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 | 221.74 on 03/21/24 |
| 3-Month | |||||
| %Chg | +7.16% since 01/19/24 | -12.63% since 01/19/24 | -23.50% since 01/19/24 | -9.37% since 01/19/24 | -22.24% since 01/19/24 |
| Low | 72.24 on 02/14/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 101.00 on 02/28/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 | 252.17 on 01/22/24 |
| 6-Month | |||||
| %Chg | +88.56% since 10/19/23 | -4.16% since 10/19/23 | -14.86% since 10/19/23 | +8.08% since 10/19/23 | -24.45% since 10/19/23 |
| Low | 43.89 on 10/25/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 101.00 on 02/28/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,440,680 | 140,812,720 | 82,374,304 | 101,698,464 | 27,694,178 |
| Shares Outstanding, K | 61,200 | 535,919 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 249,380,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -506,980,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 71,960,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | -110,920,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | 0.63 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.82 on 02/15/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 9.96 | 29.25 | 13.05 |